Učitavanje...
Severe Ulcerative Esophagitis Induced by Crizotinib Therapy
Crizotinib is an oral tyrosine-kinase inhibitor that inhibits anaplastic lymphoma kinase (ALK) in gene-rearranged non-small cell lung cancer (NSCLC). In 2011, the Food and Drug Administration approved crizotinib for treatment of locally advanced or metastatic ALK-positive NSCLC. The crizotinib adver...
Spremljeno u:
| Izdano u: | ACG Case Rep J |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American College of Gastroenterology
2014
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4435292/ https://ncbi.nlm.nih.gov/pubmed/26157832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14309/crj.2014.8 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|